271 related articles for article (PubMed ID: 19138385)
1. Factors prompting PSA-testing of asymptomatic men in a country with no guidelines: a national survey of general practitioners.
Drummond FJ; Carsin AE; Sharp L; Comber H
BMC Fam Pract; 2009 Jan; 10():3. PubMed ID: 19138385
[TBL] [Abstract][Full Text] [Related]
2. PSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UK.
Brett J; Watson E; Hewitson P; Bukach C; Edwards A; Elwyn G; Austoker J
BMC Fam Pract; 2005 Jun; 6(1):24. PubMed ID: 15946386
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen testing: uncovering primary care influences.
Gormley GJ; Catney D; McCall JR; Reilly PM; Gavin AT
BJU Int; 2006 Nov; 98(5):996-1000. PubMed ID: 17034601
[TBL] [Abstract][Full Text] [Related]
4. The PSA testing dilemma: GPs' reports of consultations with asymptomatic men: a qualitative study.
Clements A; Watson E; Rai T; Bukach C; Shine B; Austoker J
BMC Fam Pract; 2007 Jun; 8():35. PubMed ID: 17593306
[TBL] [Abstract][Full Text] [Related]
5. Doctors' approaches to PSA testing and overdiagnosis in primary healthcare: a qualitative study.
Pickles K; Carter SM; Rychetnik L
BMJ Open; 2015 Mar; 5(3):e006367. PubMed ID: 25783420
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.
Jønler M; Eddy B; Poulsen J
Scand J Urol Nephrol; 2005; 39(3):214-8. PubMed ID: 16118092
[TBL] [Abstract][Full Text] [Related]
7. Doctors' perspectives on PSA testing illuminate established differences in prostate cancer screening rates between Australia and the UK: a qualitative study.
Pickles K; Carter SM; Rychetnik L; Entwistle VA
BMJ Open; 2016 Dec; 6(12):e011932. PubMed ID: 27920082
[TBL] [Abstract][Full Text] [Related]
8. Primary goals, information-giving and men's understanding: a qualitative study of Australian and UK doctors' varied communication about PSA screening.
Pickles K; Carter SM; Rychetnik L; McCaffery K; Entwistle VA
BMJ Open; 2018 Jan; 8(1):e018009. PubMed ID: 29362252
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific antigen testing rates and referral patterns from general practice data in England.
Moss S; Melia J; Sutton J; Mathews C; Kirby M
Int J Clin Pract; 2016 Apr; 70(4):312-8. PubMed ID: 26987766
[TBL] [Abstract][Full Text] [Related]
10. GPs views and understanding of PSA testing, screening and early detection; survey.
Sutton J; Melia J; Kirby M; Graffy J; Moss S
Int J Clin Pract; 2016 May; 70(5):389-95. PubMed ID: 27121158
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the use of prostate-specific antigen as an instrument for early detection of prostate cancer beyond urologists: results of a representative cross-sectional questionnaire study of general practitioners and internal specialists.
Gilfrich C; May M; Braun KP; Lebentrau S; Lehsnau M; Ecke T; Schmailzl KJ; Al-Dumaini S; Hallmann S; Ahmed AM; Maurer J; Karl T; Braun V; Haferkamp A; Brookman-May S; Bauer RM; Stief CG; Hoschke B; Maurer O; Wolff I
Urol Int; 2014; 93(2):160-9. PubMed ID: 24603136
[TBL] [Abstract][Full Text] [Related]
12. Prostate-specific antigen screening: An update of physician beliefs and practices.
Hall IJ; Rim SH; Massetti GM; Thomas CC; Li J; Richardson LC
Prev Med; 2017 Oct; 103():66-69. PubMed ID: 28793236
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific antigen testing among the elderly in community-based family medicine practices.
Hudson SV; Ohman-Strickland P; Ferrante JM; Lu-Yao G; Orzano AJ; Crabtree BF
J Am Board Fam Med; 2009; 22(3):257-65. PubMed ID: 19429731
[TBL] [Abstract][Full Text] [Related]
14. [Early detection of prostate cancer by PSA testing: the results of a qualitative study on barriers caused by physicians in Austria implementing informed decision making].
Malli G
Gesundheitswesen; 2013 Jan; 75(1):22-8. PubMed ID: 22836936
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
[TBL] [Abstract][Full Text] [Related]
16. [Prostate cancer screening using prostate-specific antigen: The views of general and laboratory physicians].
Giménez N; Filella X; Gavagnach M; Allué JA; Pedrazas D; Ferrer F;
Semergen; 2018 Sep; 44(6):409-419. PubMed ID: 29574008
[TBL] [Abstract][Full Text] [Related]
17. Prostate specific antigen testing in family practice: a cross sectional survey of self-reported rates of and reasons for testing participation and risk disclosure.
Carey M; Bryant J; Yoong SL; Russell G; Barker D; Sanson-Fisher R
BMC Fam Pract; 2013 Dec; 14():186. PubMed ID: 24321004
[TBL] [Abstract][Full Text] [Related]
18. A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer.
Kim SP; Karnes RJ; Nguyen PL; Ziegenfuss JY; Thompson RH; Han LC; Shah ND; Smaldone MC; Gross CP; Frank I; Weight CJ; Beebe TJ; Tilburt JC
BJU Int; 2014 May; 113(5b):E106-11. PubMed ID: 24053213
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
Bunting PS; Goel V; Williams JI; Iscoe NA
CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
[TBL] [Abstract][Full Text] [Related]
20. General practitioners' approaches to prostate-specific antigen testing in the north-east of the Netherlands.
Kappen S; Koops L; Jürgens V; Freitag MH; Blanker MH; Timmer A; de Bock GH
BMC Fam Pract; 2020 Dec; 21(1):270. PubMed ID: 33334312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]